反激活CD73-腺酸轴减弱了STING通路的抗瘤免疫力
Nannan Fu1, Ziang Zhang1, Junmin Quan1
1State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
Biochemical and biophysical research communications
|March 26, 2024
概括
激活STING可以提升CD73和腺,这是一个反循环. 将STING激动剂与CD73抑制剂结合起来,通过调节瘤微环境中的免疫细胞,有效地抑制瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 循环GMP-AMP合成酶 (cGAS) 刺激干扰素基因 (STING) 途径对先天免疫和有前途的癌症治疗点至关重要.
- 针对cGAS-STING通路的瘤治疗由于复杂的反机制而面临挑战.
研究的目的:
- 研究癌症中cGAS-STING通路的反机制.
- 探索结合STING激动剂与CD73抑制剂用于癌症免疫治疗的治疗潜力.
主要方法:
- 评估了STING激活对免疫和癌细胞中CD73表达和腺生产的影响.
- 研究了I型干扰素 (IFN) /IFN-α/β受体 (IFNAR) 轴在STING诱导的CD73反中的作用.
- 在瘤模型中评估了将STING激动剂与抗CD73单克隆抗体 (mAbs) 结合的疗效.
主要成果:
- 发现STING激活可以增强CD73表达和腺素的产生.
- 这种CD73的反激活取决于由STING诱导的I型IFN/IFNAR信号通路.
- 组合疗法通过增加CD8+T细胞透和减少调控性T细胞 (Treg) 积累,显著抑制瘤生长.
结论:
- 激活STING会诱导一种由I型IFN/IFNAR信号介导的CD73-adenosine反循环.
- 将STING激动剂与CD73抑制剂结合起来,通过重编程瘤微环境,为癌症免疫疗法提供了一个有希望的策略.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
T Cell Activation and Clonal Selection
721
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
721
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


